Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02635412

Acronym

MAP

Enrollment

Registered

2015-12-18

Start date

2016-03-31

Completion date

2018-03-31

Last updated

2018-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbidly Adherent Placenta, Placenta Accreta

Keywords

Placenta, Accreta, Morbidly, Adherent Placenta

Brief summary

This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta.

Detailed description

This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta dispositioned for a scheduled delivery. The primary outcome will be assessed by comparing the composite neonatal morbidity and composite maternal morbidity between the two groups (delivery at 34 versus 36 weeks gestational age).

Interventions

OTHERScheduled timing of delivery

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Women with monographically morbidly adherent placenta with or without a placenta previa. * Scheduled delivery via cesarean hysterectomy

Exclusion criteria

* Delivery planned prior to 36 weeks (e.g. non-reassuring fetal status, preterm labor, severe preeclampsia, other medical/fetal indication for delivery as determined by the managing physician).

Design outcomes

Primary

Measure	Time frame
Composite neonatal morbidity	Within 72 hours of newborn discharge
Maternal neonatal morbidity	Within 72 hours of patient discharge

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026